Keller, MD, PhD, G.A., Villa Etchegoyen, MD, C., Fernandez, PharmD, PhD, N., Olivera, PharmD, PhD, N.M., Quiroga, PharmD, PhD, P.N., Diez, PhD, R.A. and Di Girolamo, MD, PhD, G. 2018. Dextropropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels. Journal of Opioid Management. 14, 5 (Sep. 2018), 335–344. DOI:https://doi.org/10.5055/jom.2018.0466.